Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

TECregen AG

History from 26 Jun 2023

UID
CHE-442.791.208
Legal form
AG
Canton
BS
Founded
26 Jun 2023
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 350k
88k175k263k350k18 Nov 2024 · CHF 162k24 Jun 2025 · CHF 210k11 Mar 2026 · CHF 350k20252026
  • shares
  • Vorzugsaktien

Record

  1. Company formed

    Founded 26 Jun 2023

    SHAB HR01-1005781644 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 162’499.90
    Shares
    1’000’000 → 1’624’999
    New shares, % of post-step shares
    38.5% (624’999 new)
    Share classes
    1’000’000 × CHF 0.10 · 624’999 × CHF 0.10 Vorzugsaktien

    Aktienkapital neu: CHF 162'499.90 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 162'499.90 [bisher: CHF 100'000.00]. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10 und 624'999 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 1'000'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006181024 ↗
  3. Capital increase

    Not assessed

    Paid by converting claims

    Nominal capital
    162’499.90 → 210’428.50
    Shares
    1’624’999 → 2’104’285
    New shares, % of post-step shares
    22.8% (479’286 new)
    Share classes
    1’000’000 × CHF 0.10 · 1’104’285 × CHF 0.10 Vorzugsaktien

    Aktienkapital neu: CHF 210'428.50 [bisher: CHF 162'499.90]. Liberierung Aktienkapital neu: CHF 210'428.50 [bisher: CHF 162'499.90]. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10 und 1'104'285 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 624'999 Namenaktien zu CHF 0.10 (Vorzugsaktien) und 1'000'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006364608 ↗
  4. Capital increase

    Likely financing

    Paid in cash

    Nominal capital
    210’428.50 → 350’066.20
    Shares
    2’104’285 → 3’500’662
    New shares, % of post-step shares
    39.9% (1’396’377 new)
    Share classes
    1’000’000 × CHF 0.10 · 2’500’662 × CHF 0.10 Vorzugsaktien

    Aktienkapital neu: CHF 350'066.20 [bisher: CHF 210'428.50]. Liberierung Aktienkapital neu: CHF 350'066.20 [bisher: CHF 210'428.50]. Aktien neu: 1'000'000 Namenaktien zu CHF 0.10 und 2'500'662 Namenaktien zu CHF 0.10 (Vorzugsaktien) [bisher: 1'000'000 Namenaktien zu CHF 0.10 und 1'104'285 Namenaktien zu CHF 0.10 (Vorzugsaktien)].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.90 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006592964 ↗

Published by 15 Mar 2026

Latest available record · 8 Oct 2026